Today's episode deals with a question from listener Michael, via LinkedIn:

What in the world has happened with CSL? Downgrading guidelines, some board member transitions, vaccine business segment demerger, and a huge drop in stock price!

Steve Wheen, Head of Healthcare, and Managing Director of Equity Research at Jarden, talks to Sean Aylmer about CSL and the rest of the healthcare sector.

This is general information only. Seek professional advice before making investment decisions.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

As an asset class, private credit is surging, worth at least $200 billion locally - and increasingly, retail investors are becoming interested in private credit. But is it a safe way to invest money? What should an investor be looking for when considering private credit?

Sean Aylmer is joined by ASIC commissioner Simone Constant to discuss ASIC's benchmark reports into public and private markets.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

Managing working capital is absolutely vital for any business - it's the part of a company’s trading that hasn’t yet translated into cashflow.

Every year, the team at McGrathNicol Advisory release their Working Capital Report - revealing how much cash is locked up within Australian companies, and how they stack up against the rest of the world.

Jason Ireland and Sean Wiles - partners at McGrathNicol Advisory - talk to Sean Aylmer about the thirteenth annual Working Capital Report, and what it reveals about the health of Aussie businesses.

McGrathNicol is a supporter of Fear & Greed.

Join our free daily newsletter here.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.